Poxviruses: Defining Epitope Immunodominance
Poxviruses: Defining Epitope Immunodominance
批准号:
7698540
负责人:
Masanori Terajima
金额:
$41.08万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-15 至 2009-03-31
关键词:
Adverse effectsAgammaglobulinemiaAntigen-Presenting CellsAntigensBacteriaBindingBiological AssayCD8B1 geneCellsCellular ImmunityDNADataDevelopmentEpitopesGenesHLA A*0201 antigenHistocompatibility Antigens Class IHumanImmune responseImmunizationIncidenceInfectionLicensingLocalizedMammalian CellMethodsPeptide LibraryPeptidesPolymerase Chain ReactionPoxviridaeProteinsRecoveryRelative (related person)Research Project GrantsScreening procedureSmallpoxSmallpox VaccineSmallpox VirusesStagingSystemT memory cellT-LymphocyteT-Lymphocyte EpitopesTransfectionTransgenic MiceVaccinationVaccinesVacciniaVaccinia virusViral ProteinsVirusbasecross reactivitycytotoxicitydesignenzyme linked immunospot assayexperimental analysisneutralizing antibodynovelpreventresponsesynthetic peptide
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Immunization with vaccinia virus resulted in long-lasting protection against smallpox and was the
approach used to eliminate natural smallpox infections worldwide. This was accomplished without a detailed
understanding of human T cell responses to poxviruses. Due to concerns about the use of smallpox virus as
a bioweapon, smallpox vaccination is currently being reintroduced. Considering the relatively high incidence
of side effects, developing a safer, but effective vaccine is very important.
Vaccinia virus elicits strong cellular as well as humoral immune responses. Cellular immunity seems
to be more important for recovery from infection. Severe complications from vaccination were associated
with congenital or acquired T cell deficiencies, but not with congenital agammaglobulinemia. The presence
of neutralizing antibody alone did not prevent the development of progressive vaccinia if cell-mediated
immunity was defective. In order to analyze human T cell responses to licensed and experimental smallpox
vaccines at the single cell level, it is essential to identify T cell epitopes, especially immunodominant CD8 ¿ T
cell epitopes.
Vaccinia is a large virus and we hypothesize that we can develop a rapid approach to localize gene
fragments encoding human T cell epitopes and to identify them precisely using peptides using PCRgenerated
DNA fragments containing virus genes transfected into antigen presenting cells. Complementary
strategies will employ peptide libraries and studies in transgenic mice expressing common human MHC
class I molecules. The immunodominance of human T cell epitopes on vaccinia virus will be analyzed. The
results of this research project will provide valuable information relative to basic studies of human T cell
memory and data useful for the design and analyses of experimental smallpox vaccines. The methods we
will establish in this project may be applicable to other large viruses as well as bacteria for the definition of
human T cell epitopes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human CD8+ and CD4+ T Cells Responses to Influenza Infection and Vaccination
-
批准号:7701542
-
项目类别:
-
资助金额:$45.69万
-
财政年份:2009
-
负责人:Masanori Terajima
-
依托单位:
Human CD8+ and CD4+ T Cells Responses to Influenza Infection and Vaccination
-
批准号:8452138
-
项目类别:
-
资助金额:$31.39万
-
财政年份:--
-
负责人:Masanori Terajima
-
依托单位:
Human CD8+ and CD4+ T Cells Responses to Influenza Infection and Vaccination
-
批准号:8053882
-
项目类别:
-
资助金额:$40.7万
-
财政年份:--
-
负责人:Masanori Terajima
-
依托单位:
Human CD8+ and CD4+ T Cells Responses to Influenza Infection and Vaccination
-
批准号:8243661
-
项目类别:
-
资助金额:$40.39万
-
财政年份:--
-
负责人:Masanori Terajima
-
依托单位:
Human CD8+ and CD4+ T Cells Responses to Influenza Infection and Vaccination
-
批准号:8376576
-
项目类别:
-
资助金额:$33.09万
-
财政年份:--
-
负责人:Masanori Terajima
-
依托单位:
海外基金